… We reviewed the clinical features of 59 patients with a hematologic malignancy who developed
mucormycosis in order to evaluate the clinical spectrum of the disease, its diagnosis and …

… of mucormycosis in the hematology patient. When should I suspect mucormycosis over … As
the pathophysiology, mode of acquisition and underlying patient risk factors for mucormycosis …

… monary mucormycosis has been reported in patients with leukemia and lymphoma and …
outcome of mucormycosis diagnosed in neutropenic patients affected by hematologic neoplasms …

… observed 36 haematological patients with mucormycosis from nine … patients, mucormycosis
was diagnosed 1–65 days after invasive aspergillosis. Main clinical form of mucormycosis …

… for the diagnosis of mucormycosis in hematologic patients. Results. … hematological patients
with mucormycosis, including children (6%). Patients with localized forms of mucormycosis …

… those newly diagnosed patients with invasive mucormycosis who received L-AmB as primary
therapy. Hematologic disorders were observed in 15 (54%) patients. Pulmonary disease …

… among hematology patients was noted, with 6 of 7 cases of pulmonary mucormycosis …
Differences in the epidemiology of mucormycosis seem to exist between developed and …

… with a poor outcome in ICU patients with hematological malignancies (HM), … ill patients
with mucormycosis are limited. The objective of our study was to assess the outcome of patients …

… Our primary aim was to evaluate the aggregate mortality in hematological patients with
mucormycosis. Mortality was compared across three study periods (2000 to 2009, 2009 to 2015, …

… more fatal mucormycosis in older patients, in patients with malnutrition or with hematological
malignancies. In older studies, the major prognostic factors were hematological malignancy…